Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127764151 | 12776415 | 1 | I | 2009 | 20160919 | 20160923 | 20160923 | EXP | US-PFIZER INC-2016441089 | PFIZER | 57.00 | YR | F | Y | 103.80000 | KG | 20160923 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127764151 | 12776415 | 1 | PS | TOVIAZ | FESOTERODINE FUMARATE | 1 | 4 MG, UNK | U | 22030 | 4 | MG | MODIFIED-RELEASE TABLET | |||||||
| 127764151 | 12776415 | 2 | SS | TOVIAZ | FESOTERODINE FUMARATE | 1 | 8 MG, UNK | U | 22030 | 8 | MG | MODIFIED-RELEASE TABLET | |||||||
| 127764151 | 12776415 | 3 | SS | DETROL | TOLTERODINE TARTRATE | 1 | U | 20771 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127764151 | 12776415 | 1 | Hypertonic bladder |
| 127764151 | 12776415 | 3 | Hypertonic bladder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127764151 | 12776415 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127764151 | 12776415 | Atrial fibrillation | |
| 127764151 | 12776415 | Drug ineffective | |
| 127764151 | 12776415 | Neoplasm malignant | |
| 127764151 | 12776415 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |